GLAXONSEGlaxoSmithKline Pharmaceuticals Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 22 Apr · 12:32 IST

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.6%1-day move
₹2428.80
prior close
₹2438.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.2+0.2+0.3+2.6+1.7+0.5-0.7-2.5-4.1-0.7-4.7-2.9+5.2
Up moveDown movePending
AI summary

GlaxoSmithKline Pharmaceuticals has informed exchanges about newspaper advertisements published in Economic Times, Business Standard and Maharashtra Times. The ads cover two regulatory initiatives: (1) A special window for share transfer opened since February 5, 2026, running until February 4, 2027, allowing shareholders to submit transfer requests where share transfer deeds were executed before April 1, 2019, with shares to be credited only in demat form and locked in for one year. (2) The Saksham Niveshak Campaign, a 100-day initiative by IEPF Authority from April 1 to July 9, 2026, to reach shareholders with unpaid or unclaimed dividends or incomplete KYC details. This is filed under Regulation 47 of SEBI's LODR requirements.

Likely market impact

This is a routine regulatory compliance filing with minimal direct impact on the stock. It provides an opportunity for shareholders holding physical shares with old transfer deeds to regularize their holdings before the window closes. No material financial or operational implications for the company.